← All companies
BTSG
BrightSpring Health Services, Inc.
$60.47
-12.41 -17.03%
Key statistics
from XBRL data in SEC filingsMarket cap
$12.0B
Revenue (TTM)
$14.4B
Net income (TTM)
$364M
EPS (TTM)
$1.65
P/E ratio
36.6
Dividend yield
—
Free cash flow
$395M
Cash
$550M
Total assets
$5.99B
Gross margin
12.4%
52-week range
$19.01 – $73.75
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Jul 31, 2026
8-K
Results of operations (earnings release)
Jul 31, 2026
8-K
Director or officer change; Regulation FD disclosure
Jun 12, 2026
8-K
Entered a material agreement
Jun 5, 2026
8-K
Shareholder vote results
May 21, 2026
10-Q
Quarter ended 2026-03-31
May 1, 2026
8-K
Results of operations (earnings release)
May 1, 2026
8-K
Completed an acquisition or disposition; Director or officer change; Regulation FD disclosure
Mar 31, 2026
8-K
Entered a material agreement
Mar 4, 2026
10-K
Fiscal year ended 2025-12-31
Feb 27, 2026
8-K
Results of operations (earnings release)
Feb 27, 2026
10-Q
Quarter ended 2025-09-30
Oct 28, 2025
8-K
Results of operations (earnings release)
Oct 28, 2025
8-K
Entered a material agreement
Oct 22, 2025
8-K
Results of operations (earnings release)
Oct 20, 2025
10-Q
Quarter ended 2025-06-30
Aug 1, 2025
8-K
Results of operations (earnings release)
Aug 1, 2025
8-K
Director or officer change
Jun 20, 2025
8-K
Entered a material agreement
Jun 12, 2025
8-K
Other events
Jun 10, 2025
8-K
Shareholder vote results
Jun 3, 2025
10-Q
Quarter ended 2025-03-31
May 2, 2025
8-K
Results of operations (earnings release)
May 2, 2025
8-K/A
Director or officer change
Apr 15, 2025
10-K
Fiscal year ended 2024-12-31
Mar 6, 2025
8-K
Results of operations (earnings release)
Mar 6, 2025
8-K
Director or officer change; Regulation FD disclosure
Mar 5, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Jan 21, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure
Dec 11, 2024
8-K
Director or officer change
Nov 15, 2024
10-Q
Quarter ended 2024-09-30
Nov 1, 2024
8-K
Results of operations (earnings release)
Nov 1, 2024
8-K
Director or officer change
Oct 11, 2024
8-K
Director or officer change; Regulation FD disclosure
Sep 30, 2024
10-Q
Quarter ended 2024-06-30
Aug 2, 2024
8-K
Results of operations (earnings release)
Aug 2, 2024
8-K
Unregistered sale of equity
Jun 24, 2024
8-K
Director or officer change
May 31, 2024
10-Q
Quarter ended 2024-03-31
May 2, 2024
8-K
Results of operations (earnings release)
May 2, 2024